May 2, 2019
UChicago Medicine Blood Cancer Program is one of the largest programs in the US and has been at forefront of research, treatment, and national clinical trials for complex blood cancers such as Leukemia, Lymphoma and Multiple Myeloma. Especially, we are the leader in cellular therapy research and clinical care. We were leaders in clinical trials of two types of cellular therapy, stem cell transplants and CAR T-cell therapy, and became among the first to bring these breakthrough approaches to our patients.
In the eighth volume of UChicago Medicine International Newsletter, featured are incredible stories of our blood cancer patients who could defeat cancer with UChicago Medicine.
In addition, we are excited to announce we host UChicago Medicine China Forum 2019 in Beijing on May 17th, 2019 where our cancer experts will present new research and clinical updates in leukemia and cellular therapies from UChicago Medicine. We cordially invite you and your colleagues to the forum and look forward to meeting with you all in Beijing.
To view the newsletter in English, please CLICK HERE.
To view the newsletter in Chinese, please CLICK HERE.